跳至主要内容
附件 II 条目 1564 CMR已修订 30 七月 2020

Gallium arsenide

Gallium arsenide 在附件 II 中被列为在欧盟市场上市的化妆品的禁用物质。

禁用物质— 附件 II, 欧盟法规 1223/2009
条目: 1564
CMR

记录详情

化学名称

Gallium arsenide

化学名称 / IUPAC 名称

Gallium arsenide

监管信息

法规

(EU) 2019/831

查看该法案设定的所有条目

CMR

类别CarcinogenicMutagenicReprotoxic
Cat. 1B✓—✓

关键数据

附件
条目编号
1564

化学身份与性质

CAS 1303-00-0 的 PubChem 二维化学结构
CAS 1303-00-0PubChem CID 14770

Gallium arsenide

Gallium Arsenide can cause cancer according to California Labor Code. — California Office of Environmental Health Hazard Assessment (OEHHA)

IUPAC 名称
gallanylidynearsane
分子式
AsGa
分子量
144.645 g/mol
精确质量
143.84717 Da
拓扑极性表面积
0.0 Ų
氢键供体
0
氢键受体
0
共价单元
1
已定义的立体中心
0

又称

Gallium arsenide (GaAs)Gallium monoarsenideGallium monoarsenide (GaAs)GaAs27FC46GA44Gallium ArsenatumRefChem:58150215-114-8
另有 15 个已报告名称
CCRIS 4020HSDB 4376EINECS 215-114-8arsinogallaneUNII-27FC46GA44GalliummonoarsenideGallium Arsenide, piecesEC 215-114-8GALLIUM ARSENIDE [MI]Gallium arsenide, pieces, 99.999% trace metals basisGallium arsenide Optical Window, 12.7mm (0.5in) dia x 1mm (0.04in) thickGallium arsenide Optical Window, 12.7mm (0.5in) dia x 2mm (0.08in) thickGallium arsenide Optical Window, 25.4mm (1.0in) dia x 2mm (0.08in) thickGallium arsenide Optical Window, 50.8mm (2.0in) dia x 2mm (0.08in) thickGallium arsenide, (single crystal substrate), <100>, diam. x thickness 2 in. x 0.5 mm

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配14770

Attributed physical-property, hazard, environmental and use annotations.

  • Substance: Gallium Arsenide 来源: NTP Technical Reports
  • NTP Technical Report: TR-492: Toxicology and Carcinogenesis Studies of Gallium Arsenide (CASRN 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) (2000 ) 来源: NTP Technical Reports
  • Peer Review Date: 05/21/99 来源: NTP Technical Reports
  • Conclusion for Male Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Rat: Clear Evidence 来源: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Mice: No Evidence 来源: NTP Technical Reports
  • Summary: Under the conditions of these 2-year inhalation studies, there was no evidence of carcinogenic activity of gallium arsenide in male F344/N rats exposed to 0.01, 0.1, or 1.0 mg/m3. There was clear evidence of carcinogenic activity in female F344/N rats based on increased incidences of benign and malignant neoplasms in the lung. Increased incidences of benign neoplasms of the adrenal medulla and increased incidences of mononuclear cell leukemia were also considered to be exposure related. There was no evidence of carcinogenic activity in male or female B6C3F1 mice exposed to 0.1, 0.5, or 1.0 mg/m3.; Exposure to gallium arsenide caused a spectrum of nonneoplastic lesions in the lung of rats and mice, the larynx of male rats and hyperplasia of the tracheobronchial lymph node in mice. 来源: NTP Technical Reports
  • Carcinogen Classification: 1, carcinogenic to humans. (L135) 来源: Toxin and Toxin Target Database (T3DB)
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Ap 来源: CAMEO Chemicals
  • Signal: Danger 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity]; H360F: May damage fertility [Danger Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for 6.2% (7 of 112) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H350 (88.4%): May cause cancer [Danger Carcinogenicity]; H360 (50.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H372 (88.4%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 112 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 7 of 112 reports by companies.; There are 6 notifications provided by 105 of 112 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: NITE-CMC
  • GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity]; H360: May damage fertility or the unborn child [Danger Reproductive toxicity]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: NITE-CMC
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P308+P316, P318, P319, P321, P405, and P501 (click each P-code to see the statement) 来源: NITE-CMC
  • Signal: Danger 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Health Effects: Arsenic poisoning can lead to death from multi-system organ failure, probably from necrotic cell death, not apoptosis. Arsenic is also a known carcinogen, esepcially in skin, liver, bladder and lung cancers. (T1, L20) 来源: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Arsenic and its metabolites disrupt ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. Arsenic's carginogenicity is influenced by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The binding of other arsenic protein targets may also cause altered DNA repair enzyme activity, altered DNA methylation patterns and cell proliferation. (T1, A17) 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

该记录的直接匹配结果有限,因此同时显示附件 II 中的相邻条目。

附件 II 1565
同一附件中的相邻记录

Vinyl acetate

CAS: 108-05-4
EC: 203-545-4

附件 II 对 Gallium arsenide 意味着什么

Gallium arsenide 被列为欧盟化妆品法规 1223/2009 附件 II 中的禁用物质,不得有意添加。第 17 条另行规定了在良好生产规范下技术上不可避免、且符合第 3 条安全要求的非有意微量存在的情形。

配方师必须筛查其成分和原料,确保均不含该物质。供应商应在被要求时提供证明不含该物质的文件。

本页还显示 12 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。

合规核查清单

  • 核实该物质不存在于所有原料和成品配方中。
  • 向原料供应商索取不含该物质的确认函或 CoA。
  • 将筛查结果记录在产品信息档案 (PIF) 中。
  • 该物质具有 CMR 分类。使用前请查看上方的 CMR 表,并核实现行附件 II/III 状态。

常见问题

是。Gallium arsenide 列于欧盟化妆品法规 1223/2009 的附件 II,禁止作为化妆品成分有意添加。第 17 条对在良好生产规范下技术上不可避免的非有意微量存在规定了狭窄的例外,前提是产品仍符合第 3 条的安全要求。

CAS 1303-00-0 是化学文摘社 (Chemical Abstracts Service) 分配给 Gallium arsenide 的唯一数字标识符。在化妆品合规工作中,CAS 编号用于在监管数据库、原料规格书和安全评估报告之间交叉引用该物质。如果同一物质在不同条件下或不同附件中出现,多个欧盟附件条目可能共用同一 CAS 编号。

Gallium arsenide 在欧盟 CLP 法规下具有 CMR(致癌、致突变或生殖毒性)分类。根据欧盟化妆品法规 1223/2009 第 15 条,1A 类或 1B 类 CMR 物质禁止用于化妆品,除非被特别允许。2 类 CMR 物质只有经 SCCS 评估为安全才可使用。使用前请务必核实现行附件状态及任何适用的豁免。

使用本站的 INCI 检查器工具粘贴您的完整成分表 (INCI),并对照所有附件 II–VI 条目进行扫描。该工具会突出显示与限用、禁用或致敏原标记记录相匹配的成分。这有助于对成品配方或原料声明进行快速合规筛查。

附件 II 记录 Gallium arsenide 的来源说明

本页概述欧盟委员会公开化妆品资料中 Gallium arsenide 的一条附件 II 记录,并在可用时补充关联的清单或标识符匹配。

请使用本记录页面查看 Gallium arsenide 的附件 II 条件,但任何最终监管决定都应对照现行官方附件措辞和来源文件确认。

工具与后续步骤

检查您的配方

粘贴完整的 INCI 成分表,一次性检出 Gallium arsenide 及其他被标记的欧盟附件记录。

INCI 检查器

条目对比

将 Gallium arsenide 与另一条附件记录并排对比,查看限制、浓度和附件归属的差异。

对比

浏览附件

查看附件 II 中的所有记录,并对比该附件中各物质的监管条件。

打开附件 II